Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2005
05/25/2005CN1620509A Herbal composition for improving oral hygiene, and methods of using same
05/25/2005CN1620508A Transgenic organism
05/25/2005CN1620507A Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
05/25/2005CN1620506A Selective plant growth using d-amino acids
05/25/2005CN1620505A Pim-3 kinase as a target for type 2 diabetes mellitus
05/25/2005CN1620500A Corona-virus-like particles comprising functionally deleted genomes
05/25/2005CN1620499A Igamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux
05/25/2005CN1620498A Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability
05/25/2005CN1620468A Novel anti-igf-ir antibodies and uses thereof
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620466A Cystine-knot fold protein
05/25/2005CN1620310A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
05/25/2005CN1620251A Cultured and encapsulated pancreatic stem cells
05/25/2005CN1618976A Method of inducing AcInv antisense gene to culture low temperature resistant saccharification potato strain
05/25/2005CN1618973A Fusion polynucleotide fusion polypeptide pessessing salt resistance character and expression carrier
05/25/2005CN1618972A Regulation of quinolate phosphoribosyl transferase expression
05/25/2005CN1618958A Human cholesteryl ester synthetase-2c and its coding sequence
05/25/2005CN1618957A Human cholesteryl ester synthetase-2b and its coding sequence
05/25/2005CN1618955A CHO/dhfr cell fixed point integrated expression system
05/25/2005CN1618954A Bioderived amnion, composite bioderived amnion and its preparation method
05/25/2005CN1618811A Cell surface molecule mediating cell adhesion and signal transmission
05/25/2005CN1618277A Automated system and method for harvesting and multi-stage screening of plant embryos
05/25/2005CN1203183C Retroviral vectors comprising functional splice donor site and a functional splice acceptor site
05/25/2005CN1203180C BASB006 polynucleotide(s) and polypeptide from neisseria meningitis
05/25/2005CN1203177C Tumor antigen proteins, genes thereof and tumor antigen peptides
05/25/2005CN1203092C Process for preparing transgenic coat producing milk containing human granulocyte-colony stimulating factor
05/25/2005CA2448831A1 Multi-stage cascade boosting vaccine
05/24/2005US6897359 Carnation antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants
05/24/2005US6897358 For altering any starch-storing plant, preferably cereals, in particular wheat, so that it synthesizes a modified starch
05/24/2005US6897294 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/24/2005US6897292 For detecting a genetic abnormality, cancer
05/24/2005US6897290 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H
05/24/2005US6897068 Polynucleotide complex delivery
05/24/2005US6897066 For diagnosis/therapy of human genetic disorders; in situ genetic engineering/cloning
05/24/2005US6897064 Cell or tissue-culturing carrier, and culturing method
05/24/2005US6897063 Accessory functions for use in recombinant AAV virion production
05/24/2005US6897061 Into multipotent cells (neurons/astrocytes/oligodendrocytes) in vitro; stem cells; nerve/fibroblast growth factors; extracellular matrices
05/24/2005US6897060 Composition comprising multipotent neural stem cells for generation of hematopoietic cells
05/24/2005US6897054 For controlling in vitro cell proliferation; genetic engineering
05/24/2005US6897045 Adeno-associated virus vectors
05/24/2005US6897041 For treating/preventing staphylococcal infections; transcription regulators; ion exchange resins; bacteriophages; genetic engineering/cloning
05/24/2005US6897040 Methods and host cells for improved cell culture
05/24/2005US6897039 For treatment of cardiovascular diseases.
05/24/2005US6897033 Fungal lipase
05/24/2005US6897030 CDNA sequence encoding porcine brain natriuretic peptide and related genes encoding canine and human peptides with natriuretic activity are disclosed. The gene is shown to make accessible the DNAs encoding analogous natriuretic peptides in
05/24/2005US6896884 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
05/24/2005CA2395637C Methods and compositions for organ decellularization
05/24/2005CA2133316C In vitro generation of human dendritic cells and uses thereof
05/24/2005CA2037607C Humanised antibodies
05/24/2005CA1341484C Tissue plasminogen activator having zymogenic or fibrin specific properties
05/19/2005WO2005045396A2 Use of particulate labels in bionalyte detection methods
05/19/2005WO2005045035A2 RNA INTERFERENCE MEDIATED INHIBITION OF NOGO AND NOGO RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/19/2005WO2005045028A1 Cell-free notch cleavage analysis method and drug screening method
05/19/2005WO2005045026A1 Insulin-expressing human islet cell lines capable of reversibly proliferating and use thereof
05/19/2005WO2005045024A1 Promoter in the presence of organic acid and utilization thereof
05/19/2005WO2005045012A1 Endodermal stem cells in liver and methods for isolation thereof
05/19/2005WO2005045011A1 Method of isolating and culturing mesenchymal stem cell derived from cryopreserved umbilical cord blood
05/19/2005WO2005045010A1 Method of isolating and culturing mesenchymal stem cell derived from umbilical cord blood
05/19/2005WO2005045009A1 Methods for isolating t cells and uses thereof
05/19/2005WO2005045008A1 Method for inducing chondrogenesis on mesenchymal stem cells
05/19/2005WO2005045007A1 Method and system for storing stem cell in frozen state
05/19/2005WO2005045001A2 Insulin-producing cells derived from stem cells
05/19/2005WO2005044999A2 Treatment with immunoregulatory t cells
05/19/2005WO2005044982A2 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells
05/19/2005WO2005044981A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
05/19/2005WO2005044972A2 A three-dimensional carrier for culturing microbiological material
05/19/2005WO2005044326A1 Use of a hydrogel for the culture of chondrocytes
05/19/2005WO2005044299A1 Cytoprotective effects of ethyl pyruvate
05/19/2005WO2005026330B1 Matrix derived from whole organ
05/19/2005WO2005025517A9 Animal model for protease activity and liver damage
05/19/2005WO2005021720A3 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
05/19/2005WO2004094590A3 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
05/19/2005WO2004072264A3 Fate determination by hes 1 in hematopoietic stem-progenitor cells and uses thereof
05/19/2005WO2004045495A3 Interacting site for gp41 on gp120 of hiv-1
05/19/2005WO2004024749A3 Thermostable reverse transcriptases and uses thereof
05/19/2005WO2004016726A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
05/19/2005WO2003106492A8 Marker for stem cells and its use
05/19/2005WO2003066805A3 Antisense modulation of complement component c3 expression
05/19/2005WO2003057713A3 Proteases producing an altered immunogenic response and methods of making and using the same
05/19/2005WO2003029419A3 Three dimensional structure of crystalline grp94 binding domain, and its methods of use
05/19/2005WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
05/19/2005WO2003009815A3 Compositions and methods for modulating blood-brain barrier transport
05/19/2005WO2001016286A3 A tryptamine treated, human differentiated, neuronal alzheimer-like cell and attendant methods of cell modeling
05/19/2005US20050108795 Soybean variety XB21R05
05/19/2005US20050108794 Transgenic seeds for propagaton of soybean cyst nematode resistant plants; enhancing yield of crop plants
05/19/2005US20050108793 Auxin-inducible gene, ARGOS, that is involved in organ development, including size control, in plants; transgenic plants
05/19/2005US20050108787 Plant expression vector comprising nucleotide sequences coding acetohydroxyacid synthase (AHAS) for use as tool in generating imidazolinone herbicide resistant plants
05/19/2005US20050108786 Promoter molecules for use in plants
05/19/2005US20050108785 Using nuclear transplantation as tool in generating transgenic cells for treatment and prevention of liver, nervous system, cardiovascular and bone disorders; regenerative medicine
05/19/2005US20050108784 Expression vector comprising nucleotide sequences coding spinocerebellar ataxia-1 gene for use in treatment and prevention of nervous system disorders
05/19/2005US20050108781 Expression vector comprising nucleotide sequences coding heterologous polypeptides for use as gene transfer and expression tool; bioreactors
05/19/2005US20050107601 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders
05/19/2005US20050107597 Nucleotide sequences coding microorganismal secondary response gene (SPA-1) for as tool in diagnosis, prevention and treatment of pseudomonal infection
05/19/2005US20050107592 Lipid binding protein 1
05/19/2005US20050107589 Membrane fusion protein for use as toole in the treatment and prevention of inflammatory bowel and autoimmune diseases
05/19/2005US20050107317 Nucleic acid molecule of the short-chain dehydrogenase gene family, an antibody, an aptamer or receptors, polypeptide encoded thereby; biodrug for treatment of metabolism of triglycerides, metabolic disorders as obesity, eating disorder, cachexia, diabetes mellitus, hypertension, heart disease
05/19/2005US20050107314 Modulation of cd200 receptors
05/19/2005US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
05/19/2005US20050107258 Auxinic analogues of indole-3-acetic acid
05/19/2005US20050106731 siRNA-mediated gene silencing with viral vectors